POC(Point of Care) Áø´Ü ½ÃÀå : ¿¹Ãø(2025-2030³â)
Point of Care Diagnostic Market - Forecasts from 2025 to 2030
»óǰÄÚµå : 1775321
¸®¼­Ä¡»ç : Knowledge Sourcing Intelligence
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 141 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,950 £Ü 5,555,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 4,550 £Ü 6,399,000
PDF (Multiple User License) help
PDF º¸°í¼­¸¦ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 9,775,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

POC(Point of Care) Áø´Ü ½ÃÀåÀº CAGR 6.03%·Î, 2025³â 367¾ï 2,500¸¸ ´Þ·¯¿¡¼­ 2030³â¿¡´Â 492¾ï 900¸¸ ´Þ·¯·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

POC(Point-of-Care) Áø´Ü ½ÃÀåÀº ÀüÅëÀûÀÎ °Ë»ç½ÇÀÌ ¾Æ´Ñ ħ´ë ¿·¿¡¼­ ¼öÇàµÇ´Â °Ë»ç¸¦ Æ÷°ýÇϸç, ±â¼ú ¹ßÀü°ú ÇコÄÉ¾î ¼ö¿ä Áõ°¡·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. È¿À²¼ºÀ» Çâ»ó½Ãŵ´Ï´Ù. ÈÞ´ë¿ë, ÇÚµåÇïµå, ÈÞ´ë¿ë ±â±âÀÇ µîÀåÀ¸·Î °Ë»ç ±â´ÉÀÌ º´¿ø¿¡¼­ °¡Á¤, ÀÀ±Þ½Ç, ÆíÀÇÁ¡À¸·Î È®´ëµÇ¾î º¸´Ù °¡±î¿î Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ºÎÀÀÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ

¸¸¼ºÁúȯ ¹× °¨¿°¼º Áúȯ Áõ°¡´Â POC(Point of Care) Áø´Ü ½ÃÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀÔ´Ï´Ù. Áß±¹, Àεµ µî ½ÅÈï ±¹°¡¿¡¼­´Â ½ÉÇ÷°ü Áúȯ°ú ´ç´¢º´ ¹ßº´·üÀÌ Áõ°¡Çϸ鼭 ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î ±¹Á¦´ç´¢º´¿¬¸ÍÀº 2021³â Àü ¼¼°è 20-79¼¼ ¼ºÀÎ 5¾ï 3,700¸¸ ¸íÀÌ ´ç´¢º´À» ¾Î°í ÀÖÀ¸¸ç, ÀÌµé ±¹°¡¿¡¼­´Â »ó´ç¼ö°¡ ´ç´¢º´À» ¾Î°í ÀÖ´Ù°í º¸°íÇϰí ÀÖ½À´Ï´Ù. UNAIDS´Â 2019³â ÀεµÀÇ 210¸¸ ¸íÀ» Æ÷ÇÔÇØ 2,060¸¸ ¸íÀÌ HIV¿¡ °¨¿°µÈ °ÍÀ¸·Î Ãß»êÇϰí ÀÖÀ¸¸ç, ÀÌ´Â Ä¡·á¸¦ °¡¼ÓÈ­Çϱâ À§ÇÑ ÇöÀå Áø´Ü ¾àǰ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¼¼°èº¸°Ç±â±¸(WHO)´Â 2020³â ÀεµÀÇ °áÇ٠ȯÀÚ ¼ö°¡ 264¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óÇϸç, ÀÚ¿øÀÌ ºÎÁ·ÇÑ È¯°æ¿¡¼­ ½Å¼ÓÇÑ Áø´ÜÀÇ Çʿ伺À» ´õ¿í °­Á¶Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ È£Èí±â¼¼Æ÷À¶ÇÕ¹ÙÀÌ·¯½º(RSV)´Â Àü ¼¼°è¿¡¼­ ¿¬°£ 400¸¸-500¸¸ ¸íÀÇ ¾î¸°À̸¦ °¨¿°½Ã۰í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ Áúº´À» È¿°úÀûÀ¸·Î °ü¸®Çϱâ À§ÇÑ POC °Ë»ç¿¡ ´ëÇÑ ¼ö¿ä¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

Áö¿ªÀû Àü¸Á

ºÏ¹Ì´Â ¿¹Ãø ±â°£ Áß COVID-19 È®ÁøÀÚ ¼ö°¡ ±ÞÁõÇϸ鼭 ½Å¼Ó °Ë»ç ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ºÏ¹Ì°¡ POC(Point of Care) Áø´Ü ½ÃÀå¿¡¼­ Å« ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ Áö¿ª¿¡¼­´Â Á¦Ç° Çõ½ÅÀÌ È°¹ßÇϰí, °¨¿°¼º ¹× ¸¸¼ºÁúȯÀÇ À¯º´·ü Áõ°¡, Á¶±â ¹ß°ß ¹× Á¤±âÀûÀÎ °Ç°­ °ËÁøÀ» Àå·ÁÇÏ´Â Á¤ºÎ Áö¿ø Á¤Ã¥ÀÇ ÇýÅÃÀ» ´©¸®°í ÀÖ½À´Ï´Ù. ¹Ì±¹°ú ij³ª´Ù´Â ¸Å¿ì Áß¿äÇÑ ½ÃÀåÀ¸·Î, ÀÇ·áºñ ÁöÃâ Áõ°¡, º´¿ø ¹× Áø´Ü ½ÇÇè½Ç ¼ö Áõ°¡, ¾÷°è °£ Àü·«Àû Á¦ÈÞ°¡ ±× ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀÌ Á¾ÇÕÀûÀ¸·Î POC ÀåºñÀÇ Ã¤ÅÃÀ» ÃËÁøÇÏ°í ºÏ¹Ì¸¦ ½ÃÀå È®´ëÀÇ ¼±µÎÁÖÀÚ·Î ÀÚ¸®¸Å±èÇϰí ÀÖ½À´Ï´Ù.

ƯÈ÷ ºÏ¹ÌÀÇ ¸¸¼ºÁúȯ ¹× °¨¿°¼º Áúȯ Áõ°¡, ÈÞ´ë¿ë ±â±âÀÇ ±â¼ú ¹ßÀü, ÇコÄɾî Á¤Ã¥ÀÇ Áö¿øÀ¸·Î ÀÎÇØ ÇöÀåÁø´Ü ½ÃÀåÀº ºü¸£°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå °³¹ßÀº ¼±Áø±¹°ú ½ÅÈï ½ÃÀå ¸ðµÎ¿¡¼­ ´Ù¾çÇÑ È¯°æ¿¡¼­ ½Å¼ÓÇÏ°í °£ÆíÇÑ Áø´Ü¿¡ ´ëÇÑ ¿ä±¸¿Í Áß¿äÇÑ ÇコÄɾî À̽´¿¡ ´ëÇÑ ´ëÀÀ¿¡ ÀÇÇØ ´õ¿í ÃËÁøµÇ°í ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÁÖ¿ä ÀåÁ¡

¾î¶² ¿ëµµ·Î »ç¿ëµÇ´Â°¡?

»ê¾÷ ¹× ½ÃÀå ÀλçÀÌÆ®, »ç¾÷ ±âȸ Æò°¡, Á¦Ç° ¼ö¿ä ¿¹Ãø, ½ÃÀå ÁøÃâ Àü·«, Áö¿ªÀû È®Àå, ¼³ºñ ÅõÀÚ °áÁ¤, ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ© ¹× ¿µÇâ, ½ÅÁ¦Ç° °³¹ß, °æÀïÀÇ ¿µÇâ

Á¶»ç ¹üÀ§

±â¾÷¼Ò°³

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå ½º³À¼ô

Á¦3Àå ºñÁî´Ï½º »óȲ

Á¦4Àå ±â¼ú Àü¸Á

Á¦5Àå °Ë»çº°, POC(Point of Care) Áø´Ü ½ÃÀå

Á¦6Àå Ç÷§Æûº°, POC(Point of Care) Áø´Ü ½ÃÀå

Á¦7Àå ¸ðµåº°, POC(Point of Care) Áø´Ü ½ÃÀå

Á¦8Àå ÃÖÁ¾»ç¿ëÀÚº°, POC(Point of Care) Áø´Ü ½ÃÀå

Á¦9Àå Áö¿ªº°, POC(Point of Care) Áø´Ü ½ÃÀå

Á¦10Àå °æÀï ȯ°æ°ú ºÐ¼®

Á¦11Àå ±â¾÷ °³¿ä

Á¦12Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The point of care diagnostic market is expected to grow from USD 36.725 billion in 2025 to USD 49.209 billion in 2030, at a CAGR of 6.03%.

The point-of-care (POC) diagnostics market, encompassing bedside testing performed outside traditional laboratory settings, has seen significant growth driven by technological advancements and rising healthcare needs. POC testing enables rapid evaluation, diagnosis, prognosis, and screening, reducing errors and improving efficiency. The availability of portable, handheld, and transportable devices has expanded testing capabilities beyond hospitals to homes, emergency care, and convenience clinics, meeting the growing demand for accessible diagnostics.

Market Drivers

The increasing prevalence of chronic and infectious diseases is a primary driver of the POC diagnostics market. In emerging nations like China and India, the rising incidence of cardiovascular diseases and diabetes has heightened demand. For instance, the International Diabetes Federation reported in 2021 that 537 million adults aged 20-79 globally were living with diabetes, with significant numbers in these countries. Similarly, infectious diseases such as HIV and tuberculosis (TB) are fueling market growth. UNAIDS estimated 20.6 million people were living with HIV in 2019, including 2.1 million in India, driving demand for POC diagnostics to accelerate treatment. The World Health Organization noted India's high TB burden, with 2.64 million cases in 2020, further emphasizing the need for rapid diagnostics in resource-limited settings. Additionally, respiratory syncytial virus (RSV) affects four to five million children annually worldwide, contributing to the demand for POC testing to manage such disorders effectively.

Geographical Outlook

North America is poised for significant growth in the POC diagnostics market during the forecast period. The surge in COVID-19 cases has been a key factor, increasing the need for rapid testing solutions. The region benefits from robust product innovation, a rising incidence of infectious and chronic diseases, and supportive governmental initiatives promoting early detection and regular health check-ups. The United States and Canada are pivotal markets, driven by increased healthcare expenditure, a growing number of hospitals and diagnostic laboratories, and strategic collaborations among industry players. These factors collectively enhance the adoption of POC devices, positioning North America as a leader in market expansion.

The POC diagnostics market is expanding rapidly due to the rising prevalence of chronic and infectious diseases, technological advancements in portable devices, and supportive healthcare policies, particularly in North America. The market's growth is further propelled by the need for rapid, accessible diagnostics in diverse settings, addressing critical healthcare challenges in both developed and emerging regions.

Key Benefits of this Report:

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Point of Care Diagnostics Market Segmentation

By Testing

By Platform

By Mode

By End-User

By Geography

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

3. BUSINESS LANDSCAPE

4. TECHNOLOGICAL OUTLOOK

5. POINT OF CARE DIAGNOSTICS MARKET BY TESTING

6. POINT OF CARE DIAGNOSTICS MARKET BY PLATFORM

7. POINT OF CARE DIAGNOSTICS MARKET BY MODE

8. POINT OF CARE DIAGNOSTICS MARKET BY END-USER

9. POINT OF CARE DIAGNOSTICS MARKET BY GEOGRAPHY

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

11. COMPANY PROFILES

12. APPENDIX

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â